Genome-wide Association Studies-GWAS
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Statistical Significance
Controls in Experiments
Strategies for Assessing and Addressing Confounding
Wald-Wolfowitz Runs Test II
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 24, 2025

Large-Scale Multi-Omics Genome-Wide Association Studies Mo-GWAS: Guidelines for Sample Preparation and Normalization
Published on: July 27, 2021
Sarah E Benstock1, Katherine Weaver1, John M Hettema1
1Department of Psychiatry and Behavioral Sciences, Texas A&M University School of Medicine, College Station, TX, USA.
This study introduces an ordinal model for genome-wide association studies (GWAS), enhancing statistical power by including subthreshold and asymptomatic controls. This approach offers a 10% power increase, comparable to expanding sample size.
04:41Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
Published on: August 21, 2016
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: